Search Results for: darvocet

Featured Stories
Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Thousands of Darvon, Darvocet Lawsuits Expected

Personal injury attorneys are preparing Darvocet and < "http://www.yourlawyer.com/topics/overview/darvon">Darvon litigation against the makers of propoxyphene-based painkillers. It seems that the alleged cardiac response to the drugs could be fatal with erratic origins that provide no symptoms, noted the Daily Mail. Attorneys … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs |

Motion Filed to Consolidate Darvon, Darvocet Lawsuits in Multidistrict Litigation

Attorneys representing a 31-year-old Queens, New York Woman in a < "http://www.yourlawyer.com/topics/overview/darvocet">Darvocet lawsuit have petitioned the Judicial Panel on Multidistrict Litigation to consolidate all federal lawsuits involving Darvon, Darvocet and other propoxyphene medications in a multidistrict litigation in US District … Continue reading

Posted in Legal News, Pharmaceuticals |

Darvon, Darvocet Recall Delay May Have Killed Thousands

How many Darvon and Darvocet deaths may have occurred while the US Food & Drug Administration (FDA) waited to pull these and other dangerous propoxyphene-based drugs from the market? It’s probably impossible to know for sure, but according to the … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet, Other Narcotic Painkillers May Put Elderly at Risk for Heart Attacks, Other Side Effects

Narcotic painkillers, a class of drugs that includes Oxycontin, as well as the now-recalled medications Darvon and Darvocet, may increase the risk of heart attacks and bone fractures in elderly arthritis patients, a new study has found. According to a … Continue reading

Posted in Pharmaceuticals |

Darvocet Lawsuit Filed on Behalf of New York Woman

A < "http://www.yourlawyer.com/topics/overview/darvocet">Darvocet lawsuit has been filed on behalf a 31-year-old New York woman who says the recalled painkiller caused her to suffer a near-fatal cardiac arrhythmia. The plaintiff is being represented by the national < "http://www.yourlawyer.com/">personal injury law firm … Continue reading

Posted in Legal News, Pharmaceuticals |

Darvocet Class Action Lawsuit Says Painkiller Caused Heart Attack

A propoxyphene-containing painkiller has been named in a Darvocet class action lawsuit filed by a woman who claims it caused her to suffer a heart attack. Darvocet, as well as Darvon, were pulled from the market by Xanodyne Pharmaceuticals Inc. … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Recall Came 30 Years Too Late

The Darvon and Darvocet recall announced last month due to the drugs’ association with serious and sometimes fatal heart rhythm problems was about 30 years too late. For at least that long, patient advocates had raised questions about the safety … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Withdrawal Prompts Other Propoxyphene Recalls

Following the earlier Darvon and Darvocet recall by Xanodyne Pharmaceuticals Inc., makers of generic propoxyphene medications have begun recalling their products. Recently, Cornerstone Therapeutics Inc. said it would remove three such propoxyphene products from the market, including Balacet 325. Propoxyphene … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Patients Should Discuss Alternatives with Their Doctors

The recent Darvocet and Darvon recall from the market because of their association with dangerous, and even fatal heart rhythm problems has caused consternation among people who relied on Darvon and Darvocet to manage chronic pain. But according to a recent article … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Withdrawal Late in Coming

The decision to finally pull Darvon and Darvocet from the market has spawned criticism of the US Food & Drug Administration (FDA) by those who say it waited too long to act on the dangerous painkillers. Darvon and Darvocet have … Continue reading

Posted in Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.